Summit Securities Group’s Sanofi SNY Stock Holding History

Summit Securities Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,600	Closed	-$80K	–	1336
2021 Q4	$80K	Buy	+1,600	New	+$79.1K	﹤0.01%	713

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Summit Securities Group's SNY Position: Q4 2025 in Review

Summit Securities Group sold out of Sanofi (SNY) in Q4 2025, closing a stake of 96,355 shares — an estimated $4.55M sold.

Summit Securities Group first reported a position in SNY in Q2 2014 and held it in 12 quarters. The position peaked at $9.67M in Q1 2023. 754 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

Summit Securities Group reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
Summit Securities Group sold 96,355 Sanofi shares in Q4 2025, an estimated $4.55M.
Summit Securities Group first reported a position in Sanofi in Q2 2014 and held it in 12 quarters.
Summit Securities Group's Sanofi position peaked at $9.67M in Q1 2023.
754 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on Summit Securities Group's 13F filing for Q4 2025, filed 17 Feb 2026.